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Summary
Objectives: To investigate the importance of time in pregnancy and neonatal sex on
the association between maternal metabolic parameters and neonatal sum of
skinfolds.
Methods: This was a longitudinal, secondary analysis of the vitamin D and lifestyle
intervention for gestational diabetes mellitus study, conducted in nine European
countries during 2012 to 2015. Pregnant women with a pre-pregnancy body mass
index (BMI) of ≥29 kg/m2 were invited to participate. We measured 14 maternal
metabolic parameters at three times during pregnancy: <20 weeks, 24 to 28 weeks,
and 35 to 37 weeks of gestation. The sum of four skinfolds assessed within 2 days
after birth was the measure of neonatal adiposity.
Results: In total, 458 mother-infant pairs (50.2% female infants) were included.
Insulin resistance (fasting insulin and HOMA-index of insulin resistance) in early
pregnancy was an important predictor for boys' sum of skinfolds, in addition to
fasting glucose and maternal adiposity (leptin, BMI and neck circumference)
throughout pregnancy. In girls, maternal lipids (triglycerides and fatty acids) in the
first half of pregnancy were important predictors of sum of skinfolds, as well as
fasting glucose in the second half of pregnancy.
Conclusions: Associations between maternal metabolic parameters and neonatal
adiposity vary between different periods during pregnancy. This time-dependency
is different between sexes, suggesting different growth strategies.
K E YWORD S
foetal growth, foetal programming, maternal health, metabolic syndrome, neonatal body
composition, pregnancy
1 | INTRODUCTION
Globally, in 2017 an estimated 38 million children under 5 years of
age presented either overweight or obesity. This is a major public
health concern.1 Hence, strategies have to be developed to reduce
this burden and prevent childhood obesity. This requires a thorough
identification and understanding of the underlying determinants.
Maternal obesity in pregnancy is linked with the development of
neonatal and childhood adiposity.2-5 Although there is much interest
in the relationship between maternal obesity and childhood adiposity,
maternal metabolic factors driving the increase in offspring adiposity
have not been fully understood.
The Hyperglycemia and Adverse Pregnancy Outcome study
showed a continuous positive relationship of maternal glucose in
the second trimester with measures of neonatal body fat.6 Findings
from the Healthy Start Study support this and, in addition, showed
temporal changes in the association of glucose and neonatal fat,
with stronger associations in the second half of pregnancy com-
pared to early pregnancy.7,8 However, other studies clearly indicate
that the influence of maternal phenotype on foetal growth can
already be demonstrated in the early pregnancy period: foetal
abdominal circumference, as proxy for foetal overgrowth, is
increased in women with obesity and/or gestational diabetes (GDM)
already at 20 weeks of gestation or even before9,10; maternal insulin
resistance in the first half of pregnancy is related to neonatal fat
percentage,7 and fasting glucose in the first trimester with the risk
of a large-for-gestational age baby.11 Although these studies suggest
an influence of the early pregnancy period, surprisingly little is
known about temporal relations between maternal metabolic mea-
sures and neonatal fat accrual.12
Female neonates are known to be more insulin resistant,13,14
which might explain why males are more affected by in utero expo-
sure to gestational diabetes.9 Therefore, it is mandatory to assess
temporal relations of maternal metabolism with neonatal adiposity in
a sex-dependent manner.
In this study, we investigated the association between maternal
health measures at different times during pregnancy and neonatal
sum of skinfolds in a sex-specific manner. We hypothesized that:
(a) associations between maternal metabolic parameters and neonatal
adiposity differ at different time points, and (b) these temporal differ-
ences are sex-specific. We tested these hypotheses in 458 mother-
infant pairs in the vitamin D and lifestyle intervention for gestational
diabetes mellitus (DALI) study, a pan-European study originally
designed for the prevention of gestational diabetes.15
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2 | METHODS
2.1 | Design and participants
This is a longitudinal, secondary analysis of the DALI study, which was a
multicentre parallel randomized trial conducted in nine European countries
(Austria, Belgium, Denmark, Ireland, Italy, Netherlands, Poland, Spain and
United Kingdom) during 2012 to 2015. The study was prospectively regis-
tered as a randomized clinical trial (RCT) with the primary aim to prevent
gestational diabetes mellitus on November 21, 2011 (ISRCTN70595832).
Local ethics committee approval and written informed consent of all
women was obtained. Pregnant women with a pre-pregnancy body mass
index (BMI) of ≥29 kg/m2, <20 weeks of gestation, a singleton pregnancy
and aged ≥18 years were invited to participate.16 Exclusion criteria
included diagnosis with early gestational diabetes mellitus,17,18 pre-
existing diabetes, and chronic medical conditions.
2.2 | Design and procedures
The study was originally designed as an RCT with the following
groups, pre-stratified for site: (a) healthy eating; (b) physical activity;
(c) healthy eating + physical activity; (d) healthy eating + physical
activity + vitamin D; (e) healthy eating + physical activity + placebo;
(f) vitamin D; (g) placebo, (h) control. Staff involved with measure-
ments, but not participants, were blinded to the lifestyle intervention.
Both staff and participants were blinded to vitamin D intervention.
For the purpose of this analysis, the data were analyzed as a longitudi-
nal cohort. Maternal measurements took place at baseline
(<20 weeks), at 24 to 28 and at 35 to 37 weeks of gestation. Since
methodology has been extensively described elsewhere,16 only vari-
ables of interest will be detailed in this manuscript.
2.3 | Measurements
2.3.1 | Neonatal outcome
Triceps, subscapular, supra-iliac and quadriceps skinfolds were mea-
sured within 48 hours of birth with a Harpenden skinfold calliper
(Baty, UK), and the values summed to obtain the primary neonatal
outcome measure, the sum of skinfolds. Each skinfold measurement
was measured twice and if a difference of more than 0.2 mm was reg-
istered, a third measurement was performed and the average of the
three was taken. The neonatal age at the measurement was the time
between birth and measurements, which was registered in hours.
2.3.2 | Maternal metabolic and adiposity
parameters
Maternal height was determined at baseline with a stadiometer (SECA
206; SECA, UK). Women were weighed on calibrated electronic scales
(SECA 888 and 877, SECA, UK) at baseline (<20 weeks), 24 to
28 weeks, and at 35 to 37 weeks of gestation. BMI was calculated as
weight in kilogram divided by the square of height in metres. Gesta-
tional weight gain was defined as the change in objectively measured
weight from pre-pregnancy to <20, <20 to 24-28 weeks and from
24-28 to 35-37 weeks. Neck circumference was obtained in a stand-
ing relaxed upright position between mid-cervical spine and mid-
anterior neck, to within 1 mm.19
After fasting for 10 hours, blood was collected and mothers con-
sumed a 250 mL 75 g glucose drink (within a period of 5 minutes).
Further blood collections took place after 60 and 120 minutes. All the
samples were centrifuged and separated aliquots of plasma (1000 μL
or 250 μL) placed in microrack tubes and stored at −20C or −80C in
the central trial laboratory, prior to analysis, in Graz, Austria. The
maternal concentrations of plasma fasting glucose, fasting insulin, tri-
glycerides, free fatty acids and leptin were quantified. For insulin and
leptin commercially available Enzyme-Linked Immuno Sorbent Assays
were used. In the samples taken 60 and 120 minutes after glucose
load, only glucose (1-hour glucose and 2-hour glucose) and insulin
(1-hour insulin and 2-hour insulin) were assessed. Fasting insulin resis-
tance was derived from homeostasis model assessment (HOMA-index
of insulin resistance – HOMA-IR).20 Insulin secretion after glucose
load were calculated with the Stumvoll first phase and Stumvoll sec-
ond phase validated equations.21
2.3.3 | Covariates
Information on possible covariates was collected in the baseline ques-
tionnaire or from medical files: national site(s) of recruitment, maternal
age, gestational age during pregnancy (<20, 24 to 28 and 35 to
37 weeks), maternal ethnicity (European or non-European descent),
maternal education (low, medium and high), smoking status at 35 to
37 weeks of gestation (yes/no), pre-pregnancy BMI and gestational
age at birth.
2.4 | Statistical analyses
All analyses were performed in STATA version 13 for windows
(StataCorp LP, College Station, Texas) and a 5% type I error rate
was used for the analyses. We have 80% statistical power to
detect associations with small effect sizes (f2 = 0.04) considering
the number of participants evaluated (n = 458) and the number of
exposures and confounding variables in each of our models.
Skewed variables were log-transformed before analyses (fasting
insulin, 1-hour insulin, 2-hour insulin, HOMA-IR, Stumvoll first
phase, Stumvoll second phase, triglycerides, leptin and BMI). Inde-
pendent t tests were performed to evaluate descriptive differences
in the mother's metabolic and adiposity parameters for each preg-
nancy period in relation to their child's sex (results shown in
Table 1). Independent t tests also evaluated sex-differences in neo-
natal skinfolds.
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We conducted principal component factor analyses for each mea-
surement time during pregnancy to group the exposures with shared
variances in the same factor. All components from the mother's health
profile were included in the factor analyses: fasting glucose, 1-hour
glucose, 2-hour glucose, fasting insulin, 1-hour insulin, 2-hour insulin,
HOMA-IR, Stumvoll first phase, Stumvoll second phase, triglycerides,
free fatty acids, leptin, neck circumference, BMI and gestational
weight gain. Independent of the pregnancy period, the scree plot
determined that four factors were relevant to be estimated. Thus, four
factors were estimated for each time during pregnancy by the follow-
ing criteria:
1. Independent of the time during pregnancy, each factor should be
composed of the same variables;
2. Each factor was composed of variables with high loading factors
(≥0.4) in at least two measuring points after varimax rotation of
the correlation matrix;
3. Components with high loading factors (≥0.4) in more than one fac-
tor were only included in the factor with the highest loading
factor;
4. Factors were estimated using the linear regression prediction
score.
At all three time points during pregnancy, factor 1 was composed
of fasting insulin and HOMA-IR (representing insulin resistance); fac-
tor 2 was composed of 1-hour insulin, 2-hour insulin, Stumvoll first
phase and Stumvoll second phase (representing insulin response); fac-
tor 3 was constituted of 1-hour glucose and 2-hour glucose (rep-
resenting glucose tolerance), and, factor 4 was composed of leptin,
BMI and neck circumference (representing maternal adiposity).
Table S1 presents the cumulative variance of each factor in the three
periods of gestation. Fasting glucose, triglycerides, free fatty acids and
gestational weight gain did not have a high loading factor for any of
the factors, nor did they built a separate factor, and were not included
in any of the factors. Thus, they were analyzed as single exposures in
relation to neonatal sum of skinfolds.
The association of each resulting factor from the mother's health
profile with neonatal sum of skinfolds was assessed using linear multi-
level analyses, adjusted for intervention group, site of recruitment,
gestational age during pregnancy, gestational age at birth, neonatal
age at measurement, maternal ethnicity, maternal education, BMI
(except in factor 4 since BMI was part of this factor), maternal age,
smoking status and the cluster structure. Sex-effects were estimated
by inclusion of an interaction term between the factor and sex. We
used robust correction for estimating the standard errors and esti-
mated P-values using the Bonferroni adjustment for multiple testing.
The association between the mother's health profile not included in
any of the factors (fasting glucose, triglycerides, free fatty acids and
gestational weight gain) and neonatal sum of skinfolds was evaluated
following the same procedure abovementioned. Note that we tested
the same analysis replacing BMI for gestational weight gain as a con-
founder. The conclusions were similar, so we only present the results
with BMI adjustment.
2.5 | Supplementary analysis
Multiple linear multilevel analyses tested the association between
each of the maternal measurements during pregnancy and neonatal
sum of skinfolds (see Table S2). Sex-effects were estimated by inclu-
sion of an interaction term between the exposures and sex. All ana-
lyses were adjusted for intervention group, site of recruitment,
maternal ethnicity, education, BMI (except when BMI was the expo-
sure), age, smoking status, gestational age during pregnancy (<20,
24 to 28 and 35 to 37 weeks), gestational age at birth (weeks) and
neonatal age at measurement (hours post birth). The cluster structure
of data was also taken into account with individuals nested into the
site of recruitment. We used robust correction for estimating the
standard errors and used the Bonferroni adjustment for multiple test-
ing. Analyses with triglycerides and fatty acids as exposures were fur-
ther adjusted for HOMA-IR.
3 | RESULTS
In total, 458 mother-infant pairs (50.2% female infants) were included
in the study. On average, the mothers were 32.1 (±5.3) years of age
and their infants were measured 19.9 (±30.5) hours after birth. Mothers
gave birth after 39.7 (±1.4) weeks of gestation, and most mothers per-
ceived themselves as of European descent (84.6%) and did not smoke
during pregnancy (85.6%). More than half of the mothers (57.6%)
reported high educational level, whereas 32.0% reported medium edu-
cational level. Neonatal boys exhibited lower sum of skinfolds com-
pared to girls (Mean sum of skinfoldsboys = 20.3 mm [±5.2]; Mean sum
of skinfoldsgirls = 21.5 mm [±5.4]; P = .02).
3.1 | Maternal metabolic parameters at three time
points
Table 1 describes the unadjusted sex-differences in the mothers'
metabolic profile for each gestational time. In the first measurement
prior to 20 weeks of gestation, no differences were observed in
maternal metabolic measurements between mothers of boys and
girls. At 24 to 28 weeks of gestation, mothers of girls had higher
fasting insulin, HOMA-IR and Stumvoll first and second phases com-
pared to mothers of boys. At 35 to 37 weeks of gestation, mothers
of girls had higher fasting glucose compared to those of boys
(Table 1).
3.2 | Associations of maternal metabolic
parameters with neonatal adiposity
Associations of the four factors, and fasting glucose, triglycerides,
fatty acids and gestational weight gain at the three time points with
neonatal adiposity are described in Table 2. Factor 1 (fasting insulin
and HOMA-IR) at <20 weeks of gestation was associated with boys'
LIMA ET AL. 5 of 11
sum of skinfolds, and with girls' sum of skinfolds at 35 to 37 weeks of
gestation. Factor 2 (1-hour insulin, 2-hour insulin, Stumvoll first phase,
Stumvoll second phase) was associated with boys' sum of skinfolds at
35 to 37 weeks of gestation, and no association was found of this fac-
tor with girls' sum of skinfolds. Factor 3 (1-hour glucose and 2-hour
glucose) at 35 to 37 weeks of gestation was associated with boys'
sum of skinfolds and at 24 to 28 and 35 to 37 weeks of gestation with
girls' sum of skinfolds. Finally, factor 4 (leptin, BMI and neck circum-
ference) was associated with boys' sum of skinfolds in all pregnancy
periods, but not with girls' sum of skinfolds (Figure 1).
Fasting glucose at <20, 24 to 28 and 35 to 37 weeks of gestation
was associated with boys' sum of skinfolds, and at 24 to 28 and 35 to
37 weeks of gestation with girls' sum of skinfolds. Triglycerides at
<20 weeks were positively associated with the sum of skinfolds in
girls, and 35 to 37 weeks with sum of skinfolds of boys. Fatty acids
were associated with sum of skinfolds in girls at <20 and 24 to
28 weeks. Gestational weight gain at <20 weeks was positively asso-
ciated with boys' sum of skinfolds (Table 2). Table S2 describes the
associations of maternal parameters that were included in the factors
with neonatal adiposity.
4 | DISCUSSION
The main aim of the present study was to identify the effect of some
maternal metabolism on neonatal skinfolds at different times in preg-
nancy in a sex-dependent manner. Results confirmed our hypotheses
that associations of metabolic parameters with neonatal adiposity
change between different time-periods and differ between sexes. We
demonstrate a complex pattern of metabolic metabolism and its asso-
ciation with neonatal fat measured as sum of skinfolds, as illustrated
in Figure 2. In summary, insulin resistance in early pregnancy is an
important predictor for boys' sum of skinfolds, in addition to fasting
glucose throughout pregnancy. In girls, maternal lipids in the first half
of pregnancy period play a role for sum of skinfolds, as well as fasting
glucose in the second half of pregnancy.
In both sexes, the early pregnancy period is relevant for neonatal
adiposity, although for different metabolic parameters (ie, insulin
resistance in boys and lipid levels in girls). Although a later interven-
tion was effective in reducing neonatal adiposity,22 our data suggest
that ideally maternal metabolism shall be normalized already early in
pregnancy to reduce the risk of neonatal adiposity. Hence, interven-
tions beginning prior to or in very early pregnancy might be even
more effective than those initiated later, and achieved a 9% reduction
in neonatal fat.22 Our results also indicate that both types of nutrients,
glucose and lipids, are related to neonatal adiposity, although associa-
tions are time- and sex-dependent. This argues for future time- and
sex-specific studies to delineate metabolic pathways between mater-
nal adiposity, insulin resistance, the different nutrients and neonatal
adiposity.
The physiological pathways influencing neonatal adiposity origi-
nate from maternal insulin resistance, which is higher with increasing
maternal BMI. Indeed, in the Healthy Start Study7 maternal insulin
resistance in the first half of pregnancy was an independent predictor
TABLE 2 Multilevel regression coefficients of the association between maternal health profile components and child's sum of skinfolds (mm)
by sex in three periods of gestation
Maternal parameters
Boys Girls
<20 weeks 24-28 weeks 35-37 weeks <20 weeks 24-28 weeks 35-37 weeks
β P β P β P β P β P β P
Factor 1
Fasting insulin and HOMA-IR
1.091 .006 .130 .713 .445 .103 .536 .094 .339 .372 .347 .044
Factor 2
1-h and 2-h insulin, and Stumvoll first
and second phases
.458 .163 .305 .256 .673 .009 .389 .228 .449 .215 .208 .521
Factor 3
1-h and 2-h glucose
.384 .362 −.241 .617 1.083 .022 .529 .280 1.387 .012 1.520 .020
Factor 4
Leptin, BMI and neck circumference
1.136 .004 1.114 .008 1.342 .008 .349 .196 .505 .100 .596 .152
Fasting glucose (mmol/L) 1.792 <.001 1.406 .011 2.085 .019 −.045 .968 2.475 .008 1.361 .035
Triglycerides (log) 1.428 .423 .235 .854 2.740 .005 2.005 .031 1.907 .119 1.395 .235
Fatty acids (mmol/L) 1.555 .152 .462 .787 1.179 .544 3.886 <.001 4.942 .011 −1.678 .203
Gestational weight gain (kg) .197 .033 −.003 .975 .059 .645 .021 .646 .125 .345 .010 .526
Note: Adjusted for intervention group, site of recruitment, maternal ethnicity, education, BMI (except when BMI was the exposure), age and smoking
status, gestational age during pregnancy (weeks), gestational age at birth (weeks) and neonatal age at measurement (hours), and cluster structure
(individuals nested in site of measurement). Besides the aforementioned adjustments, HOMA-index was also an adjustment when triglycerides and fatty
acids were the exposures. P values are Bonferroni adjusted.
Abbreviation: BMI, body mass index.
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of neonatal adiposity. This is in principle in line with our findings of
insulin resistance (represented by factor 1) in early pregnancy playing
a role, but in our study, this was limited to boys only. Later in preg-
nancy, the positive association of insulin resistance with neonatal adi-
posity was found in both boys and girls. The strong determining role
of early insulin resistance for neonatal adiposity is not without prece-
dent and extends to the pre-pregnancy period, in which insulin resis-
tance had the strongest association with neonatal fat mass, more so
than insulin resistance in late pregnancy.23 However, neither of those
previous studies tested for sex differences in this association or, spe-
cifically, in pregnant women with obesity. Two studies that analyzed
boys and girls separately24,25 found associations of insulin resistance
late in pregnancy with measures of adiposity in girls, but not in boys,
which is not fully in line with our findings. The different finding might
be explained by differences in maternal BMI or the participants' level
of glucose tolerance, since those other studies were not limited to
women with obesity without GDM at baseline, as in our study
sample.24,25
The pathway from insulin resistance to neonatal adiposity might
be through one of the nutrients glucose or lipids.8 Although found in
various populations,7,24-26 the role of fasting glucose for neonatal adi-
posity in women with obesity is a novel finding to the best of our
knowledge. Maternal fasting glucose was a driver of fat accretion
throughout pregnancy in boys and mainly in later pregnancy in girls.
The sex difference in early pregnancy might explain why the Healthy
Start Study7 only found an association of fasting glucose after
20 weeks of gestation, but not before, with neonatal adiposity. The
reasons for the sex-difference in the timing of the association of
fasting glucose with neonatal fat remain speculative. The glucose steal
phenomenon posits foetal hyperinsulinemia, the main driver of fat
accretion, as the result of maternal hyperglycemia from early on.27 A
sex-difference in the timing of the glucose steal may be one explana-
tion for our findings, but this remains to be studied.
Interestingly, independent of maternal insulin sensitivity, lipids in
the first half of the pregnancy period were associated with sum of
skinfolds in girls. In boys, only triglycerides at 35 to 37 weeks were
related with neonatal skinfolds. This sex interaction in the association
of lipids with neonatal skinfolds might explain the lack of association
in previous studies not distinguishing between sexes.7,19,20 To compli-
cate matters further, the association of maternal lipids with neonatal
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F IGURE 1 Multilevel regression coefficients of the association between (A) factor 1 (fasting insulin and HOMA-index); (B) factor 2 (1-hour
insulin, 2-hour insulin, Stumvoll phase 1 and Stumvoll phase 2); (C) factor 3 (1-hour glucose and 2-hour glucose) and (D) factor 4 (leptin, BMI and
neck circumference) and neonatal sum of skinfolds (mm) by sex in three periods of gestation. Adjusted intervention group, site of recruitment,
gestational age during pregnancy, gestational age at birth, neonatal age at measurement, maternal ethnicity, maternal education, body mass index
(BMI), except in the factor 4 since BMI was part of this factor, maternal age, smoking status and cluster structure (individuals nested in site of
measurement)
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adiposity might also depend on maternal metabolic status and/or
weight. Crume et al7 observed that maternal triglycerides, in middle to
late pregnancy, were associated with neonatal fat mass only in women
with obesity before pregnancy. In a study including women with a
normal glucose metabolism and those with gestational diabetes,
maternal lipids, triglycerides and free fatty acids in late pregnancy
were positively associated with neonatal fat mass only in women with
gestational diabetes, but not in women with normal glycaemia.28 This
complex interaction between maternal phenotype, neonatal sex and
maternal lipid profile could be a reason why in a Mendelian randomi-
zation approach no causal effect of maternal triglyceride concentra-
tions on offspring birth weight was found.29 Mendelian randomization
is a powerful method for establishing causal exposure-outcome rela-
tions. The present results call for using this method in a sex-specific
manner, and at the same time distinguishing between women with
different weight status. Moreover, neonatal fat percentage is the rele-
vant offspring outcome more sensitive to in utero influences, and
hence, more variable than birth weight.
While analysis of the insulin secretory response (factor 2) did not
result in a clear picture, glucose tolerance (factor 3) at the end of preg-
nancy was related to neonatal adiposity for boys and girls. Conflicting
results have been found on the association of glucose tolerance with
neonatal adiposity. Most,7,25,30 but not all,23 studies reported positive
associations. None of those assessed sex differences, and importantly,
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<20 weeks 24-28 weeks 35-37 weeks
Pregnancy period
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F IGURE 2 Summarized visualization of the degree of importance of some maternal parameters in relation to neonatal sum of skinfolds by sex
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only one study evaluated exclusively pregnant women with obesity.
Thus, more information is needed to draw any conclusions on the role
of insulin secretory response or glucose tolerance for neonatal
adiposity.
Maternal adiposity, mostly assessed by the pre-pregnancy BMI,
has been related with neonatal adiposity in numerous
studies,4,5,25,31-33 although one reported no association.34 We found
maternal adiposity to be associated with neonatal adiposity in boys
throughout pregnancy, but no association was found in girls.
Although, when analyzed individually, maternal BMI in the second half
of pregnancy period was associated with the girls' adiposity. Different
from many of the previously mentioned studies, we only had women
with obesity in our sample, which might have precluded finding strong
associations with maternal adiposity. Reports on sex differences in
the association of maternal adiposity and neonatal adiposity are con-
flicting: Some find associations only in boys,35 but other studies only
in girls.36,37 Prior studies in pregnant women with diabetes have
reported an interaction of foetal sex with a number of maternal vari-
ables in the prediction of large or small-for-gestational age new-borns
but results are not comparable since the outcome variable was not
new-born adiposity and maternal variables did not include lipids or
insulin sensitivity.38
4.1 | Sex and time differences
Conceptually, male and female foetuses follow different growth strat-
egies in utero.39,40 Mechanisms are not well understood, but male
embryos have more rapid cell divisions compared to females,41 which
could lead to a more rapid growth.39,40 Their higher growth rate might
explain why male foetuses are also more responsive to changes in
nutrient supply.39,40 In addition, the peak growth velocity of males
seems to be later in pregnancy compared to female foetuses.39 These
different growth strategies might result in differences in nutritional
needs, at different times in pregnancy. The results of our study pro-
vide strong evidence to support this concept. However, more system-
atic assessments of time- and sex-dependent associations of maternal
metabolism with neonatal adiposity are needed in future studies.
Although foetal fat is mostly accumulated late in pregnancy,42,43
our data highlight that also the early pregnancy period is important for
neonatal adiposity. This finding is in line with other studies, showing
that maternal metabolism that led to gestational diabetes diagnosis
later in pregnancy, had an influence on foetal abdominal circumfer-
ence already at 17 weeks of pregnancy, with a more pronounced
effect in males.9 Also maternal obesity was related to accelerated
growth at 20 weeks of gestation,10 without sex differences studied.
4.2 | Strengths and limitations
The European representativeness of our study sample with trials sites
spread over Europe is a strength, but the restriction to women with
obesity can be seen as a limitation of our study. However, since the
prevalence of pregnant women with obesity is alarming,44 studying
the consequences of maternal obesity is of public health relevance. A
strength of our study is the measurements of maternal metabolic
parameters at three time points in pregnancy. Without this elaborate
approach, identification of time-dependent effects had not been
possible.
DALI study was designed to evaluate the effects of different
interventions on preventing gestational diabetes in pregnant women
with obesity. Although we adjusted the analyses for the various inter-
ventions, we cannot fully exclude a minor influence on the results.
While more direct measures of neonatal adiposity by for example, air
displacement plethysmography, would have been preferred, we
recently reported an association of sum of skinfolds with cord blood
leptin in this cohort,22 supporting the validity of the skinfold measures
as proxy for neonatal adiposity.
5 | CONCLUSION
Our results show time-dependent associations of maternal metabolic
parameters with neonatal adiposity. Importantly, and a novel key
result, we demonstrate that this time-dependence varies between
sexes. Thus, the study highlights the urgent need for inclusion of neo-
natal sex in all analyses, not as confounder, but as major determinant
and modifying factor. This has been recommended previously.45,46
The present study can inform future studies to include larger sample
sizes, because of the sex differences, but also measurements of
maternal metabolism at more than one time point during pregnancy.
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